Clinical Trials Browser

Phase 2 × Sezary Syndrome × Temozolomide × Clear all

NCT00004106 2012-06-06

Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Phase 2 Terminated

DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous